Anruize

Anruize (Beijing) Technology is a leading Site Management Organization (SMO) in China, providing specialized clinical trial support services to pharmaceutical, biotechnology, and medical device companies. Founded in 2014 and acquired by Tigermed shortly thereafter, the company focuses on the management of Clinical Research Coordinators (CRCs) to ensure the high-quality execution of clinical trials at research sites. Anruize offers services including site feasibility, patient recruitment, data entry, and regulatory document management across a broad spectrum of therapeutic areas. By optimizing site-level operations, the company helps sponsors accelerate clinical development timelines and maintain rigorous compliance with Good Clinical Practice (GCP) standards. As a key subsidiary of Tigermed, Anruize leverages a vast network of hospital sites across China to support both domestic and international clinical programs.